Number of shares and votes in EQT

EQT issued 80,360,882 ordinary shares as consideration for its completed combination with Coller Capital, which closed on 31 August 2026. As of 30 September 2026, EQT had 1,245,922,458 shares outstanding. The announcement formalizes the transaction-related dilution and updated share count, with no new operating or financial guidance disclosed.

Analysis

The key market question is whether the acquired private-capital-management platform contributes fee-related earnings per newly issued share above EQT's trading multiple. The roughly 6.9% increase in share count raises the hurdle for accretion: absent rapid realization of fundraising, cross-selling and cost synergies, reported EPS/management-fee growth could lag the headline expansion in assets under management over the next 1-3 reporting periods. The new shareholder base may also create technical selling pressure if recipients monetize stock consideration, particularly given the relatively modest newsflow impact.

Strategically, the combination broadens EQT's exposure to secondary private-market capital, a countercyclical channel when LPs need liquidity and traditional exits remain constrained. That can improve fundraising durability over 6-18 months, but it also increases dependence on private-asset valuation marks and on secondary-market discount levels; a wider NAV discount may support deployment volumes while pressuring carried-interest realizations and transaction economics. The near-term consensus risk is treating additional AUM as immediately equivalent to higher distributable earnings.

There is no standalone directional catalyst in the share-count notice. The investable catalyst is pro forma disclosure of management fees, fee-related EBITDA margin, net debt assumed, and the expected timing of revenue/synergy capture. A meaningful upward revision to 2027 fee-related earnings would validate accretion; conversely, a share overhang, slower fundraising, or evidence that acquired economics are materially lower-margin would likely drive multiple compression versus listed alternatives peers.

Key Decisions for Investors

• Maintain a neutral EQT position pending the first pro forma earnings disclosure; do not buy solely on expanded AUM. Upgrade only if management demonstrates fee-related earnings accretion after the higher share base and provides quantified integration targets.
• Set a 1-3 month monitoring alert for abnormal EQT trading volume and block activity versus its 20-day average, which would indicate stock-consideration monetization and may create a better entry point for a 6-18 month secondary-market thesis.
• For existing EQT longs, require the next results to show management-fee growth and fee-related margin sufficient to offset approximately 6.9% dilution. Failure to establish that path is a thesis falsifier and supports reducing exposure versus diversified listed-alternatives peers.
• Watch private-equity secondary transaction discounts and exit-market reopening through 2027: tighter discounts and improving realizations support the strategic rationale, while persistently wide discounts would challenge carry and acquired-platform economics.